NewCardio, Inc.
2350 Mission College Boulevard
Suite 1175
Santa Clara,
CA 95054
United States - Map
Phone: 408-516-5000
Fax: 408-907-8923
Web Site: http://www.newcardio.com
| NewCardio, Inc., a development-stage diagnostic company, focuses on the research, development, and commercialization of products and services for the non-invasive diagnosis and monitoring of cardiovascular disease. It also involves in the cardiac safety assessment of various drugs that are under development. The companys technology platform provides real-time and 3-D analysis of the heart's electrical activity as detected at the body surface by 12-lead electrocardiogram electrodes. NewCardio, Inc. has three products under various stages of development: QTinno, an automated software tool suite, which provides QT interval data from a range of electrocardiograms; VisualECG, a set of algorithms and tools that provide a method to assess cardiac electrical activity in time and space; and CardioBip, a mobile electrocardiogram transtelephonic system comprising a mobile electrocardiogram recording and transmitting device, and a diagnostic center, which receives, processes, and analyzes the data. The company was founded in 2004 and is based in Santa Clara, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Branislav Vajdic Ph.D., 54
Chief Exec. Officer |
$
378.00K | N/A | Mr. Vincent W. Renz Jr., 52
Pres and Chief Operating Officer |
$
133.00K | N/A | Mr. Richard D. Brounstein , 59
Chief Financial Officer, Principal Accounting Officer, Exec. VP and Sec. |
$
250.00K | N/A | Dr. Ihor Gussak M.D., Ph.D., FACC,
Chief Medical Officer and VP |
$
194.00K | N/A | Dr. Dorin Panescu PhD,
Chief Technical Officer and VP of R&D |
$
86.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.50% Nasdaq 
0.02 (2.86%) 
Profile
